Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate a single ingredient product (omeprazole 20 mg) with a combination product capsule (omeprazole 20 mg + sodium bicarbonate 1100 mg) in participants with frequent heartburn.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer
• Treatments: Molecular Mechanisms of Pharmacological Action; Omeprazole; Omeprazole, sodium bicarbonate drug combination

Criteria

Inclusion Criteria:

• Females of reproductive potential must demonstrate a negative urine pregnancy test and agree to use an acceptable method of birth control

• Suffer from frequent heartburn

• Refrain from taking non-study medicine or treatment for heartburn for the duration of the study

• Be free of any clinically significant disease that requires a physician's care

• Read and understand English

Exclusion Criteria:

• Any significant medical condition which is a contraindication to the use of omeprazole or sodium bicarbonate

• Known hypersensitivity to the study drugs or any components

• Experiencing any of the following: trouble or pain with swallowing food, vomiting with blood, bloody or black stools

• Participation in another investigational study within 4 weeks prior to the screening visit.